Additionally, highly suppressive TIGIT+ Tregs were associated with a profound anti-tumor response, and some researchers hypothesize that the deprivation of TIGIT on Tregs, not on CD8+ TILs, enhances the anti-tumor response by reestablishing the cytotoxic properties of CD8+ T cells [61]. The gene discussed is TIGIT; the disease is neoplasm.